UCB (UCB-BT)


UCB stock research in summary

ucb.com


Latest Obermatt Ranks

Country Belgium
Industry Pharmaceuticals
Index BEL20
Size class X-Large

June 16, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: UCB

STOCK RESEARCH SUMMARY 2014 2015 2016 2017
STOCK VALUE RANKS
88
76
100
100
STOCK GROWTH RANKS
38
76
92
67
STOCK SAFETY RANKS
43
59
50
7
COMBINED STOCK RANKS
64
84
100
69

Last update of Combined Rank: 16-Jun-2017

Historic UCB stock analysis based on the Obermatt Method. The higher the rank, the better is UCB in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2014 2015 2016 2017
PRICE VS. REVENUES (P/S)
65
67
87
83
PRICE VS. PROFITS (P/E)
44
75
96
90
PRICE VS. CAPITAL (Market-to-Book)
86
68
88
70
DIVIDEND YIELD
94
92
94
92
CONSOLIDATED RANK: VALUE
88
76
100
100

Last update of Value Rank: 16-Jun-2017

UCB stock analysis in respect to important value ratios. The higher the rank, the lower the value ratio; except for dividend yield where the rank is higher the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2014 2015 2016 2017
REVENUE GROWTH
34
68
50
49
PROFIT GROWTH
51
82
87
82
STOCK RETURNS
51
46
83
42
CONSOLIDATED RANK: GROWTH
38
76
92
67

Financial reporting date of Growth Rank: 31-Dec-2016

UCB stock analysis in respect to important growth metrics. The higher the rank, the higher the growth and returns.


Safety Metrics in Detail

SAFETY METRICS 2014 2015 2016 2017
LEVERAGE
22
16
30
22
REFINANCING
6
LIQUIDITY
69
86
72
89
CONSOLIDATED RANK: SAFETY
43
59
50
7

Financial reporting date of Safety Rank: 9-Jun-2017

UCB stock analysis in respect ot important safety metrics. The higher the rank, the lower the leverage and the more cash is available to service the debt.

Stock analysis by the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety for UCB (UCB-BT) from June 16, 2017.